Lawyers: Investigators recommend whistleblower is reinstated
May 8, 2020
WASHINGTON (AP) — Federal investigators have found "reasonable grounds" that a government whistleblower was punished for speaking out against widespread use of an unproven drug that President Donald Trump touted as a remedy for COVID-19, his lawyers said Friday.
Dr. Rick Bright headed the Biomedical Advanced Research and Development Authority, a unit of Department of Health and Human Services that focuses on countermeasures to infectious diseases and bioterrorism. He had received a job performance review of outstanding before he was summarily transferred last month, with his agency email cut o...
For access to this article please
sign in or
subscribe.
Reader Comments(0)